2.7.2020 | New Publication
We are excited about new DigiWest data published in Laboratory Investigation.
20.3.2020 | News
The company continues to operate without a significant impact on services.
26.11.2019 | New Publications
Two publications provide new insights.
6.8.2019 | New Partner
NMI TT Pharmaservices is proud to announce its new DigiWest® partnership with LI-COR Biosciences
21.5.2019 | New Publication
We are delighted to see that our DigiWest® data contributed to this exciting Nature Communications article
10.4.2019 | New Publication
28.1.2019 | New Service
We are proud to announce the availability of DigiWest® and RPPA multiplex protein profiling from FFPE samples
25.9.2018 | New Publication
International multisite study of human induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment
31.5.2018 | CRISPR/Cas9 License
8.11.2017 | New Service
We are pleased to announce the availability of pathway panels for our DigiWest® multiplex immunoassay-based protein profiling services
11.9.2017 | New Product
28.8.2017 | New Offering
We are excited to announce our most recent offering: modified MagPlex® microspheres for Luminex® assays
22.6.2017 | Grant Awarded
NMI TT Pharmaservices and Charité received a grant for protein profiling in individualization of tumor therapy
4.11.2016 | CiPA Core Site
We are very excited that HESI changed our status from non-core to core site for the actual running CiPA myocyte study
26.9.2016 | New Publication
NMI and its CRO NMI TT Pharmaservices announce the publication of their proprietary DigiWest® protein profiling method in Nature Communications
1.8.2016 | Workshop
Come to Reutlingen, and hear about the latest advances in Reverse Phase Protein Arrays (RPPAs) and their application for biomarker research
2.5.2016 | Grant Awarded
Sentinel Oncology and NMI TT Pharmaservices awarded Eurostars grant for development of a novel biomarker for treatment of Fragile X Syndrome (FXS)
9.1.2016 | New Product
Cav1.2 ion channels are expressed in heart, smooth muscle and neurons, and therefore are therapeutic targets in cardiac arrhythmia and hypertension
22.9.2015 | New Branch
NMI TT Pharmaservices today announced that it is growing its operations by establishing a new branch at the Bayer CoLaborator in Berlin
Tools which make the necessary services and functions possible, including proof of identity, continuity of service and location safety. This option is not deniable.
Tools which gather anonymous data about website-usage and -functionality. We use those findings to improve our products, services and the user-experience.
Integration of Social Media Plugins.